Related Experiment Videos
[Malignant hyperthermia and sevoflurane--a case report]
D Claussen1, K Wuttig, J Freudenberg
1Krankenhaus am Rosarium GmbH Abteilung für Anästhesiologie und Intensivtherapie, Sangerhausen.
Summary
A child experienced malignant hyperthermia (MH) triggered by sevoflurane anesthesia. Early detection via capnometry and prompt dantrolene treatment reversed the crisis, highlighting critical monitoring for this disorder.
Area of Science:
- Anesthesiology
- Pediatric Anesthesia
- Pharmacology
Background:
- Malignant hyperthermia (MH) is a rare, life-threatening pharmacogenetic disorder of skeletal muscle.
- Previous uneventful anesthesia with halothane in this patient.
- Introduction of sevoflurane as a potential trigger in pediatric anesthesia.
Observation:
- A 5-year-old boy developed MH symptoms 45 minutes after sevoflurane induction.
- Significant increase in end-tidal CO2 to 87 mmHg and heart rate to 160 bpm.
- Blood gas analysis revealed respiratory and metabolic acidosis.
Findings:
- Sevoflurane identified as the causative agent for MH crisis.
- Rapid reversal of life-threatening signs upon dantrolene administration.
- Capnometry proved crucial for early MH detection.
Implications:
- Early recognition and prompt dantrolene treatment can significantly reduce MH morbidity and mortality.
- Continuous capnometry monitoring is essential in pediatric anesthesia.
- Further research into MH triggers and management strategies is warranted.